2024. COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF DAILY VERSUS INTERMITTENT ANTI-TUBERCULAR MEDICATION REGIMENS IN PATIENTS WITH CATEGORY 1 TUBERCULOSIS. International Research Journal of Pharmacy. 11, 9 (Nov. 2024), 39–42.